Skip to main content

Table 1 Patient Characteristics and LV function for HHD and healthy control groups

From: Sensitive marker for evaluation of hypertensive heart disease: extracellular volume and myocardial strain

 

HHD(n = 62)

Controls

(n = 26)

P value

EF < 30%

(n = 22)

30%EF < 50% (n = 18)

EF50

(n = 22)

Age (years)

43.7 ± 13.6

46.3 ± 14.8

49.3 ± 10.3

44.6 ± 13.7

0.36

Gender

20 M, 2F

16 M, 2F

19 M, 3F

22 M, 4F

0.28

BMI

30.4 ± 5.9

25.5 ± 3.5

25.7 (4.5)

24.6 ± 3.7

< 0.05a d

EF (%)

22.0 (6.6)

35.8 (14.6)

68.3 (9.3)

61.0 (7.3)

< 0.01a b e f

LVEDVI (ml/m2)

149.9 (50.1)

110.4 (43.2)

68.3 (24.7)

59.7 (23.3)

< 0.01a b e f

LVESVI (ml/m2)

122.1 (37.9)

70.2 (19.1)

21.3 (16.0)

23.4 (10.0)

0.000a b e f

LVSVI

(ml/m2)

32.0 (15.3)

45.2 (22.6)

45.5 (13.3)

35.6 (14.1)

< 0.05c d e

LVMI (g/m2)

128.3 (40.4)

115.35 (39.1)

89.5 (35.6)

44.7 (13.9)

< 0.01a b c e

EDWT (cm)

1.2 ± 0.2

1.2 ± 0.2

1.1 ± 0.2

0.8 ± 0.2

< 0.05 a b c

  1. Abbreviations: a EF < 30% compared with Controls; b 30%EF < 50% compared with Controls; c EF50 compared with Controls; d EF < 30% compared with 30%EF < 50%; e EF < 30% compared with EF50; f 30%EF < 50% compared with EF50